Sironax
Beijing
About Sironax
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases. The company is focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. They aim to shift the treatment paradigm for age-related degenerative disease to improve the lives of millions of patients and their families around the world. Sironax was founded in 2017 and is based in Beijing, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $301.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2022)
- Website: sironax.com.cn
- Phone: 86-10-80765868
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sironax-50619 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.